ICU Medical, Inc. (ICUI), Thursday reported forth-quarter net loss of $15.7 million, or $0.64 per share, as compared to a net loss of $23.8 million, or $0.97 per share, for the fourth quarter of 2024.
Adjusted earnings per share for the fourth quarter were $1.91 as compared to $2.11 for the fourth quarter of 2024.
Fourth-quarter revenue was $540.7 million, as compared to $629.8 million in the same period in the prior year.
Vivek Jain, ICU Medical's Chief Executive Officer, said, "Fourth quarter results were generally in line with our expectations."
For fiscal year 2026 the company estimates net income to be in the range of $26 million to $44 million and net earnings per share estimated to be in the range of $1.03 to $1.74.
For the fiscal year 2026, the company expects adjusted EBITDA to be in the range of $400 million to $430 million, and adjusted earnings per share to be in the range of $7.75 to $8.45.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.